Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Hydroxychloroquine × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 7 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 COVID-19 3 Ovarian Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Untreated Resectable Pancreatic Adenocarcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cancer Resectable 1 Neoplasm, Residual 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Klatskin Tumor 1 Hypoxia 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Temozolomide 140 Bevacizumab 80 Radiotherapy 69 Magnetic Resonance Spectroscopy 22 Radiation 18 Irinotecan 18 pembrolizumab 17 Lomustine 16 Carmustine 15 Surgical Procedures, Operative 13 Nivolumab 11 Erlotinib Hydrochloride 11 sargramostim 9 Thalidomide 9 Specimen Handling 9 Chemotherapy, Adjuvant 9 Aminolevulinic Acid 9 Carboplatin 8 Cilengitide 7 Sunitinib 6 Immunoglobulin G 6 Etoposide 6 Disulfides 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Radiotherapy, Intensity-Modulated 5 Radiosurgery 5 Metformin 5 Imatinib Mesylate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01602588 2018-05-03

HCQ

University College, London

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡